Besides, a recent head-to-head comparison in 15 patients afflicted with PCa using both [68Ga]PSMA-HBED-CC and [18F]AlF-PSMA-11 showed that in additional 22% of the cases, bone lesions were only discernible with the latter compound 87. This evidence concerns the gene FOLH1 and posterior cortical atrophy.